Goldman Sachs’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.19M Buy
171,690
+73,518
+75% +$2.85M ﹤0.01% 3556
2026
Q1
$3.7M Sell
98,172
-42,008
-30% -$1.37M ﹤0.01% 3983
2025
Q4
$4.22M Buy
140,180
+6,109
+5% +$173K ﹤0.01% 3898
2025
Q3
$3.52M Buy
134,071
+116,483
+662% +$2.78M ﹤0.01% 3967
2025
Q2
$375K Buy
17,588
+2,073
+13% +$46.8K ﹤0.01% 5328
2025
Q1
$330K Sell
15,515
-155,351
-91% -$3.19M ﹤0.01% 5410
2024
Q4
$3.46M Buy
170,866
+130,866
+327% +$2.7M ﹤0.01% 3810
2024
Q3
$672K Buy
+40,000
New +$674K ﹤0.01% 4889

Other funds holding GRDN

Goldman Sachs's GRDN Position: Q2 2026 in Review

Goldman Sachs increased its Guardian Pharmacy Services (GRDN) stake by 75% in Q2 2026, buying an estimated $2.85M and bringing the position to 171,690 shares worth $7.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3556.

Goldman Sachs first reported a position in GRDN in Q3 2024 and has held it in 8 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Goldman Sachs held 171,690 shares of Guardian Pharmacy Services worth $7.19M as of Q2 2026.
  • Goldman Sachs bought 73,518 Guardian Pharmacy Services shares in Q2 2026, an estimated $2.85M.
  • Guardian Pharmacy Services made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3556 holding.
  • Goldman Sachs first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 8 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.